Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05548660 · ClinicalTrials.gov registry record · NA
Pharmacogenetic-guided Choice of Post-surgery Analgesics
A NA study of Postoperative Pain and Acute Pain, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 1
- Study location
NCT05548660: Completed NA study of Postoperative Pain and Acute Pain, sponsored by University of Pennsylvania.
NCT05548660 is a NA study of Postoperative Pain and Acute Pain that has completed, run by University of Pennsylvania. The registered enrollment target is 112 participants, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05548660, a NA study of Postoperative Pain and Acute Pain, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
Pharmacogenomics (PGx) is the study of how genes affect a person's response to drugs. PGx testing for certain genes can help predict the risk of side effects or therapeutic failure from analgesics. Testing is not regularly performed in clinical practice due to long wait times for results and challenges with integrating test results in the electronic health record. Investigators leading this study hope to find out if providing surgeons with the ability to order a PGx test and electronically receive results with dosing recommendations will increase the use of these tests to guide analgesic choice and improve patient outcomes. This is a prospective, two-arm randomized implementation study. Eligible participants will be randomly assigned to receive genotype-guided analgesic selection (intervention arm) or usual care (control arm). Both cohorts will undergo pharmacogenetic testing at the time of consenting. The investigators will primarily measure the feasibility of using this test to guide analgesic selection.
Primary Outcome
Number of Participants with PGx Test Results and Pharmacist Consult Notes Returned Per Protocol. Before surgery for the PGx-guided arm, and after surgery for the Usual care arm.
Conditions Studied
Interventions
- OTHER Pharmacogenetic testing
- OTHER Pharmacist note with genotype-guided analgesic recommendations
- OTHER Pharmacist detailed note with genotype-guided recommendations per CPIC guidelines
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2022-10-13 |
| Est. Completion | 2025-02-01 |
| Phase | NA |
What the finished NCT05548660 record still lists
NCT05548660 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (52% lower).
The record links to 2 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 3 interventions - of which Pharmacogenetic testing is the first listed.
NCT05548660 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05548660 about?
NCT05548660 is a clinical study titled "Pharmacogenetic-guided Choice of Post-surgery Analgesics". Pharmacogenomics (PGx) is the study of how genes affect a person's response to drugs. PGx testing for certain genes can help predict the risk of side effects or therapeutic failure from analgesics. Testing is not regularly performed in clinical practice due to long wait times for results and challen...
What is the current status of trial NCT05548660?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2022-10-13. Estimated completion is 2025-02-01.
What conditions does trial NCT05548660 study?
This clinical trial studies the following conditions: Postoperative Pain, Acute Pain.
What interventions are being tested in trial NCT05548660?
The interventions under investigation include: Pharmacogenetic testing (OTHER), Pharmacist note with genotype-guided analgesic recommendations (OTHER), Pharmacist detailed note with genotype-guided recommendations per CPIC guidelines (OTHER).
Who is sponsoring clinical trial NCT05548660?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05548660 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05548660's enrollment target sits among peer trials
112 50th of 120 higher than 71 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
-
Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
-
Pain With Differing Insufflation Pressures During Laparoscopic Hysterectomy
RECRUITING · NA
-
Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy
RECRUITING · NA
-
Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI